Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ)
CNY 3.4
(-0.58%)
CNY 3.4
(-0.58%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 843.54 Million CNY | -16.99% |
| 2022 | 836.44 Million CNY | 6.26% |
| 2021 | 787.14 Million CNY | -1.87% |
| 2020 | 802.12 Million CNY | -15.01% |
| 2019 | 943.72 Million CNY | 1.57% |
| 2018 | 929.1 Million CNY | 27.21% |
| 2017 | 730.39 Million CNY | 2.55% |
| 2016 | 712.21 Million CNY | 28.22% |
| 2015 | 555.44 Million CNY | 39.75% |
| 2014 | 397.46 Million CNY | 29.15% |
| 2013 | 307.76 Million CNY | 32.41% |
| 2012 | 232.43 Million CNY | 22.04% |
| 2011 | 190.46 Million CNY | 12.73% |
| 2010 | 168.96 Million CNY | -1.16% |
| 2009 | 170.94 Million CNY | 15.85% |
| 2008 | 147.55 Million CNY | 42.38% |
| 2007 | 103.63 Million CNY | 20.85% |
| 2006 | 85.75 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 160.51 Million CNY | -12.67% |
| 2024 Q3 | 187.32 Million CNY | 16.7% |
| 2024 Q1 | 183.8 Million CNY | -7.07% |
| 2023 Q2 | 182.37 Million CNY | -12.68% |
| 2023 Q3 | 189.55 Million CNY | 3.94% |
| 2023 FY | 694.3 Million CNY | -16.99% |
| 2023 Q4 | 197.79 Million CNY | 4.34% |
| 2023 Q1 | 208.85 Million CNY | -1.4% |
| 2022 Q1 | 203.63 Million CNY | 8.6% |
| 2022 FY | 836.44 Million CNY | 6.26% |
| 2022 Q4 | 211.82 Million CNY | 7.22% |
| 2022 Q3 | 197.55 Million CNY | -11.58% |
| 2022 Q2 | 223.43 Million CNY | 9.72% |
| 2021 Q1 | 187.52 Million CNY | -11.2% |
| 2021 Q3 | 211.65 Million CNY | 5.58% |
| 2021 Q4 | 187.5 Million CNY | -11.41% |
| 2021 FY | 787.14 Million CNY | -1.87% |
| 2021 Q2 | 200.46 Million CNY | 6.9% |
| 2020 Q1 | 219.47 Million CNY | -12.29% |
| 2020 Q4 | 211.19 Million CNY | 10.94% |
| 2020 FY | 802.12 Million CNY | -15.01% |
| 2020 Q3 | 190.36 Million CNY | 5.12% |
| 2020 Q2 | 181.09 Million CNY | -17.49% |
| 2019 Q1 | 217.97 Million CNY | -12.22% |
| 2019 Q4 | 250.23 Million CNY | 5.66% |
| 2019 Q2 | 238.7 Million CNY | 9.51% |
| 2019 Q3 | 236.81 Million CNY | -0.79% |
| 2019 FY | 943.72 Million CNY | 1.57% |
| 2018 Q4 | 248.31 Million CNY | 13.18% |
| 2018 Q3 | 219.4 Million CNY | -10.24% |
| 2018 Q2 | 244.44 Million CNY | 12.68% |
| 2018 FY | 929.1 Million CNY | 27.21% |
| 2018 Q1 | 216.94 Million CNY | 23.19% |
| 2017 Q3 | 210.32 Million CNY | 33.2% |
| 2017 Q2 | 157.9 Million CNY | -15.14% |
| 2017 FY | 730.39 Million CNY | 2.55% |
| 2017 Q1 | 186.06 Million CNY | -18.51% |
| 2017 Q4 | 176.09 Million CNY | -16.27% |
| 2016 FY | 712.21 Million CNY | 28.22% |
| 2016 Q2 | 158.17 Million CNY | 7.97% |
| 2016 Q3 | 179.23 Million CNY | 13.31% |
| 2016 Q4 | 228.32 Million CNY | 27.39% |
| 2016 Q1 | 146.49 Million CNY | -26.93% |
| 2015 FY | 555.44 Million CNY | 39.75% |
| 2015 Q2 | 128.1 Million CNY | 37.64% |
| 2015 Q1 | 93.07 Million CNY | -23.75% |
| 2015 Q4 | 200.47 Million CNY | 49.83% |
| 2015 Q3 | 133.79 Million CNY | 4.44% |
| 2014 Q2 | 109.3 Million CNY | 85.76% |
| 2014 Q1 | 58.84 Million CNY | -40.86% |
| 2014 Q3 | 107.26 Million CNY | -1.87% |
| 2014 FY | 397.46 Million CNY | 29.15% |
| 2014 Q4 | 122.05 Million CNY | 13.79% |
| 2013 Q1 | 59.62 Million CNY | -15.95% |
| 2013 Q2 | 64.97 Million CNY | 8.97% |
| 2013 Q3 | 83.67 Million CNY | 28.78% |
| 2013 Q4 | 99.48 Million CNY | 18.9% |
| 2013 FY | 307.76 Million CNY | 32.41% |
| 2012 FY | 232.43 Million CNY | 22.04% |
| 2012 Q1 | 45.24 Million CNY | -28.16% |
| 2012 Q2 | 53.98 Million CNY | 19.31% |
| 2012 Q3 | 62.26 Million CNY | 15.33% |
| 2012 Q4 | 70.94 Million CNY | 13.95% |
| 2011 Q3 | 43.66 Million CNY | -8.51% |
| 2011 Q2 | 47.72 Million CNY | 32.23% |
| 2011 Q1 | 36.09 Million CNY | -23.43% |
| 2011 FY | 190.46 Million CNY | 12.73% |
| 2011 Q4 | 62.98 Million CNY | 44.26% |
| 2010 Q1 | 38.19 Million CNY | -25.27% |
| 2010 Q2 | 46.59 Million CNY | 22.0% |
| 2010 FY | 168.96 Million CNY | -1.16% |
| 2010 Q4 | 47.13 Million CNY | 27.29% |
| 2010 Q3 | 37.03 Million CNY | -20.53% |
| 2009 FY | 170.94 Million CNY | 15.85% |
| 2009 Q1 | 38.35 Million CNY | 0.0% |
| 2009 Q2 | 40.2 Million CNY | 4.82% |
| 2009 Q4 | 51.11 Million CNY | 23.2% |
| 2009 Q3 | 41.48 Million CNY | 3.19% |
| 2008 FY | 147.55 Million CNY | 42.38% |
| 2007 FY | 103.63 Million CNY | 20.85% |
| 2006 FY | 85.75 Million CNY | 0.0% |